Vantexa Pharmaceuticals / Quality and Compliance

Quality is built through disciplined decisions.

Understand the quality-management principles relevant to pharmaceutical manufacture, from material qualification and process validation to traceability, investigation and documented review.

Original abstract scientific quality illustration; not a product or company facility
Original editorial illustration · Manufacturing principles, not a Vantexa product or facility.
01

Quality philosophy and management

Pharmaceutical quality management

A quality system connects policies, responsibilities, procedures and records. Its purpose is to maintain a state of control, recognise risks and provide a documented basis for decisions. Oversight should extend across the product lifecycle rather than rely exclusively on finished-product testing.

Current Good Manufacturing Practice principles

cGMP principles address people, premises, equipment, materials, processes and documentation. Their application depends on the activity, product, site and jurisdiction. Discussing these principles does not establish certification, inspection status or approval by a medicines authority.

Quality assurance and quality control

Quality assurance provides system oversight, including procedure approval, review and investigation governance. Quality control evaluates materials and products against defined specifications using appropriate methods. Clear interfaces between these functions help prevent gaps in decision-making.

02

Qualification and validation

Process validation

Validation seeks documented evidence that a process can consistently deliver an outcome meeting predetermined requirements. Process understanding, risk assessment, defined protocols and evaluation of results support that conclusion. Continued monitoring is needed to assess whether control is maintained over time.

Equipment qualification

Qualification establishes a documented basis for equipment suitability. It can address design, installation, operation and performance as appropriate to the intended use. Maintenance and calibration support continued suitability; a qualification exercise does not eliminate the need for routine oversight.

Cleaning validation

Cleaning assessment considers product residues, cleaning agents, microbiological risks where relevant, equipment design and sampling limitations. Scientifically justified limits and suitable analytical methods are essential. Worst-case selection and repeatability should be explained in the supporting documentation.

03

Records, materials and suppliers

Batch records and traceability

A batch record should connect the materials used, process execution, in-process checks, equipment and personnel with the finished batch. Traceability also depends on distribution and packaging records. Records should permit an investigation to reconstruct the relevant sequence without relying on memory.

Supplier qualification and raw material quality

Supplier assessment considers material criticality, supply-chain knowledge and available quality evidence. Receipt testing, identity verification, certificates and supplier performance review contribute different information. Reliance on a supplier document must be justified within the applicable quality system.

Documentation management

Controlled documents need identifiable versions, approval, distribution and retention arrangements. Obsolete instructions should be prevented from unintended use. Records must remain readable, retrievable and protected throughout their required retention period.

04

Laboratory evaluation and stability

Laboratory testing principles

Appropriate sampling, qualified instruments, reference standards and suitable analytical methods underpin reliable results. Unexpected or out-of-specification results require a structured assessment. Repeating a test without a justified investigation can obscure the reason for the original result.

Stability studies

Stability programmes evaluate how quality attributes change under defined environmental conditions over time. Packaging, storage conditions, sampling points and test methods must suit the product and intended market. Shelf life and storage statements require supporting evidence rather than assumptions based on a similar product.

05

Investigation and controlled improvement

Deviations and corrective and preventive actions

A deviation investigation should assess impact, consider plausible causes and use available evidence to establish a justified conclusion. Corrective actions address an identified problem; preventive measures reduce recurrence or related risks. Effectiveness checks determine whether the intended improvement was achieved.

Change control

A proposed change should be assessed before implementation for effects on product quality, validated status, documentation, training and regulatory obligations. Review should involve appropriate disciplines. Closing a change requires evidence that agreed actions and any follow-up activities were completed.

Risk management

Quality risk management helps prioritise attention using scientific knowledge and the potential impact on product quality. The formality of the assessment should be proportionate to the risk and uncertainty. Risk tools support judgement; they do not replace evidence or override an applicable requirement.

Continuous quality improvement

Trend review, complaints, deviations, supplier performance and process monitoring can reveal recurring issues. Improvement priorities should have defined owners, measurable outcomes and review dates. Sustained improvement depends on checking results after implementation.

Complaints and recall preparedness

A complaint process should record the concern, identify the affected product and batch where available, assess potential quality impact and establish appropriate escalation. Recall preparedness requires traceable distribution records, defined decision responsibilities and a way to evaluate the effectiveness of any action. Product-specific reporting routes must be confirmed before commercial supply.

Management review

Periodic quality review brings together process trends, deviations, corrective actions, supplier performance and changes affecting the system. Management oversight should assess whether resources and controls remain suitable and whether previously agreed improvements have been effective.

06

People, data and regulatory responsibility

Data integrity

Reliable data should be attributable, legible, contemporaneous, original and accurate, with appropriate completeness and availability. Access control, audit trails, review practices and secure retention help preserve the meaning and provenance of records. Electronic and paper systems both require proportionate controls.

Personnel training

Personnel need role-specific instruction and an understanding of why controls matter. Training should be recorded and its effectiveness assessed where appropriate. Changes to procedures, equipment or responsibilities may require additional training before the revised activity begins.

Regulatory responsibilities

Manufacturing authorisation, product registration and market release obligations vary by jurisdiction and must be established for each arrangement. This website does not claim FDA, EMA, MHRA or other authority approval, and does not display unverified certification badges.

Quality documentation enquiries

Identify the proposed product, site or service scope, intended market and purpose of the request. Documents may require a confidentiality agreement, eligibility review or controlled disclosure. Availability of a general quality discussion does not imply that a particular certificate or audit report exists.

A considered next step

Bring your requirements into focus.

Contact our team